What are the characteristics and inheritance pattern of Familial Adenomatous Polyposis (FAP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Familial Adenomatous Polyposis: Characteristics and Inheritance

The correct answer is (a): FAP is caused by inactivation of a tumor suppressor gene. FAP results from germline mutations in the APC gene, a tumor suppressor located on chromosome 5q21-22, which plays a central role in intestinal development and homeostasis 1.

Detailed Analysis of Each Statement

(a) Caused by inactivation of a tumor suppressor gene - CORRECT

  • FAP is caused by mutations in the APC (adenomatous polyposis coli) gene, which functions as a tumor suppressor 1, 2.
  • The APC gene is located on the long arm of chromosome 5 (5q21-22) 1.
  • APC mutations are detected in approximately two-thirds or more of families affected with FAP 1, 2.
  • In remaining families without APC mutations, biallelic MUTYH gene mutations may explain a portion of cases, particularly in attenuated disease 1.

(b) Normal life expectancy after prophylactic colectomy - INCORRECT

  • While early diagnosis and proper prophylactic treatment results in excellent survival outcomes comparable to the general population 1, this statement oversimplifies the reality.
  • After colectomy, patients face significant ongoing morbidity and mortality risks from extracolonic manifestations 1.
  • Duodenal cancer and desmoid tumors are the two main causes of mortality after total colectomy 3.
  • Morbidity is caused by duodenal cancer (requiring periodic duodenoscopy) and poorly treatable desmoid tumors 1.
  • Lifelong surveillance is required for rectal polyps (if rectum preserved), duodenal and periampullary adenomas, and desmoid tumors 4.

(c) Associated with increased risk of right-side colon cancer - INCORRECT

  • FAP is characterized by universal distribution of adenomas throughout the colon and rectum, not specifically right-sided predominance 1, 4.
  • Classic FAP develops hundreds to thousands of adenomatous polyps throughout the entire colorectum 1, 3.
  • The attenuated variant (AFAP) does show polyps that tend to cluster in the proximal colon 1, but this is not the classic presentation.
  • Without surgical intervention, patients almost inevitably develop colorectal cancer by mean age 40-50 years, with 100% lifetime cancer risk 1, 3.

(d) Inherited as autosomal recessive trait - INCORRECT

  • FAP follows an autosomal dominant inheritance pattern 1, 2, 3.
  • Each child of an affected parent has a 50% chance of inheriting the predisposition 1, 2, 4.
  • Between one-third and half of new cases represent de novo mutations of the APC gene with no family history 1, 2.
  • The only recessive form is MUTYH-associated polyposis (MAP), which requires biallelic MUTYH mutations and represents a different condition 1.

Key Clinical Pitfalls

  • Do not confuse classic FAP with MUTYH-associated polyposis (MAP): MAP follows autosomal recessive inheritance and represents a distinct entity 1.
  • Do not assume normal life expectancy post-colectomy: Extracolonic manifestations, particularly duodenal cancer and desmoid tumors, remain significant causes of morbidity and mortality 1, 3.
  • Do not overlook the need for lifelong surveillance: Even after prophylactic colectomy, patients require ongoing monitoring for upper gastrointestinal tract adenomas and desmoid tumors 1, 4, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Familial Adenomatous Polyposis (FAP) Genetic Causes and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Familial adenomatous polyposis.

Orphanet journal of rare diseases, 2009

Guideline

Management and Treatment of Gardner Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.